Liver dysfunction and anti-thyroid therapy

被引:7
作者
Papachristos, Danae A. [1 ]
Huynh, Jenny [1 ]
Grossman, Mathis [2 ,3 ]
MacIsaac, Richard J. [1 ,3 ]
机构
[1] St Vincents Hosp Melbourne, Dept Endocrinol & Diabet, 41 Victoria Parade, Melbourne, Vic 3065, Australia
[2] Austin Hlth, Endocrine Ctr Excellence, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源
SAGE OPEN MEDICAL CASE REPORTS | 2015年 / 3卷
关键词
Diabetes/endocrinology; pharmacoepidemiology/drug safety; liver dysfunction; carbimazole; hyperthyroidism;
D O I
10.1177/2050313X14568335
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thioamides have been used in the management of hyperthyroidism for over 50 years. Liver dysfunction is a rare but important side effect associated with their use. Recently, cases of liver failure associated with propylthiouracil have prompted the Federal Drug Administration to issue a Boxed Warning to the label of propylthiouracil regarding its risk of potentially fatal liver injury and acute liver failure in adults and children. Herein, we present a case to underline the importance of recognising the similar potential for severe hepatic dysfunction with the use of other thioamides.
引用
收藏
页数:3
相关论文
共 8 条